Evaluation of the Safety of Relaxin in Preeclampsia
Evaluation of the Safety of Relaxin in Preeclampsia
The purpose of this study is to determine whether different doses of recombinant human
 relaxin is safe when given to women with severe preeclampsia
The effects of relaxin may be beneficial in the treatment of women with preeclampsia. This
 study will preliminarily evaluate the maternal, fetal and neonatal safety and tolerability of
 an IV infusion of relaxin compared with placebo given to women with severe preeclampsia.
Inclusion Criteria:

 -  Diagnosis of preeclampsia

 -  Hospital admission for expectant management

 Exclusion Criteria:

 -  Eclampsia or history of seizures

 -  Vaginal bleeding

 -  Multifetal gestation

 -  Requirement for immediate delivery